Biomed Central Ltd

SHERPA: Unknown

People

  1. Mangarin
    Mangarin
  2. Abdel-Wahab
    Abdel-Wahab
  3. Budhu
    Budhu
  4. Hirschhorn Cymerman
    Hirschhorn Cymerman
  5. Liu
    Liu
  6. Rampal
    Rampal
  7. George
    George
  8. Holland
    Holland
  9. Panageas
    Panageas
  10. Schulze
    Schulze

Groups

  1. Department of Medicine (7)
  2. GSK Faculty (7)
  3. Melanoma and Immunotherapeutics Service (7)
  4. Sloan Kettering Institute Postdocs (7)
  5. Solid Tumor Oncology Division (7)
  6. MSK Grad Students (5)
  7. Hematology-Oncology Fellows (4)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  9. Center for Hematologic Malignancies (3)
  10. Executive Committee, Center for Hematologic Malignancies (3)
Search Within
  1. "Mathieu Gigoux"
Formats
  1. Meeting Abstract (7)
Groups
  1. Department of Medicine (7)
  2. GSK Faculty (7)
  3. Melanoma and Immunotherapeutics Service (7)
  4. Sloan Kettering Institute Postdocs (7)
  5. Solid Tumor Oncology Division (7)
  6. MSK Grad Students (5)

More Groups

People
  1. Jedd Wolchok (7)
  2. Mathieu Gigoux (7)
  3. Taha Merghoub (7)
  4. Levi Mark Mangarin (5)
  5. Roberta Zappasodi (5)
  6. Sara Schad (4)

More People

Years
  1. 2021 (2)
  2. 2020 (2)
  3. 2019 (1)
  4. 2018 (1)
  5. 2017 (1)
Publications
  1. Journal for ImmunoTherapy of Cancer (7)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J.; Bozkus, C. C.; Mangarin, L.; Redmond, D.; Verma, S.; Schad, S.; George, M.; Venkatesh, D.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger neutrophil activation to eliminate tumor antigen escape variants
    Meeting Abstract

    Hirschhorn, D.; Budhu, S.; Schröder, D.; Kraehenbuehl, L.; Flammar, A. L.; Chow, A.; Schulze, I.; Schad, S.; Ricca, J.; Gasmi, B.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Characterizing double positive T cells in the tumor microenvironment: A tale of promiscuous cell fates
    Meeting Abstract

    Schad, S.; Chow, A.; Pan, H.; Mangarin, L.; Zappasodi, R.; Gigoux, M.; Redmond, D.; Hirschhorn-Cymerman, D.; Budhu, S.; Zhong, H.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J.; Pourpe, S.; Ghosh, A.; Bozkus, C. C.; Mangarin, L.; Redmond, D.; Verma, S.; Schad, S.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Blockade of IDO/TDO downstream effectors restricts a Treg-macrophage suppressive axis and resistance to anti-PD-1 therapy
    Meeting Abstract

    Campesato, L.; Budhu, S.; Tchaicha, J.; Gigoux, M.; Cohen, I.; Mangarin, L.; Redmond, D.; Pourpe, S.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Developing a cross-reactive heteroclitic peptide cancer vaccine targetting poorly immunogenic mutant calreticulin in myeloproliferative neoplasms
    Meeting Abstract

    Gigoux, M.; Elf, S.; Ciboddo, M.; Zappasodi, R.; Pourpe, S.; Abdelfattah, N.; Chan, T.; Abdel-Wahab, O.; Mullally, A.; Merghoub, T.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Upregulation of PD-L1 in tumor microenvironment is a resistance mechanism for oncolytic virus immunotherapy
    Meeting Abstract

    Zamarin, D.; Ricca, J.; Oseledchyk, A.; Gigoux, M.; Merghoub, T.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save